Autres langues Lupin Limited

Actions

LUPIN

INE326A01037

Temps Différé Bombay S.E. Autres places de cotation 09:17:02 23/05/2024			Varia. 5j.	Varia. 1 janv.
1 637 ^INR	-4,41 %		-1,72 %	+23,45 %

20/05	Lupin reçoit six observations de la FDA américaine après l'inspection de l'unité de Somerset	MT
09/05	LUPIN LIMITED : Nomura réitère son opinion positive sur le titre	ZM

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Lupin Gets Six Observations from US FDA After Somerset Unit Inspection	20/05
Lupin : May 16, 2024 Lupin Receives Approval from U.S. FDA for Midostaurin Capsules	16/05
Lupin : May 15, 2024 Lupin Achieves Significant Milestone with ISO 14001 and ISO 45001 Certification Across All its Indian Manufacturing Sites, R&D Center and Corporate Office	15/05
Lupin Relaunches Mirabegron ER Tablets in US	13/05
Lupin : May 9, 2024 Jeffrey Kindler and Alfonso Zulueta Join Lupin Board as Independent Directors	09/05
Lupin Limited Announces Board Appointments	09/05
Lupin's Consolidated Profit Climbs in Fiscal Q4; Shares Dip 4%	07/05
Indian drugmaker Lupin misses quarterly profit estimates as costs rise	06/05
Lupin : May 6, 2024 Lupin Receives Approval from U.S. FDA for Travoprost Ophthalmic Solution USP	06/05
Lupin Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	06/05
Lupin Limited Reports Earnings Results for the Full Year Ended March 31, 2024	06/05
Lupin : May 3, 2024 Lupin Launches Rymti® Biosimilar Etanercept in Canada	03/05
Lupin Limited Receives an Order from Office of the State Tax Inspector, Jurisdiction: Ghatak 56: Range - 14: Division - 6: Gujarat	30/04
Lupin : April 25, 2024 Lupin Receives Approval from U.S. FDA for Loteprednol Etabonate Ophthalmic Suspension, 0.5%	25/04
Lupin : April 25, 2024 Lupin Digital Health’s Lyfe Platform Receives Class C Medical Device License from CDSCO	25/04
Lupin Receives US FDA Inspection Report for Aurangabad, India Manufacturing Facility	24/04
Lupin : April 23, 2024 Lupin Receives EIR from U.S. FDA for its Aurangabad Manufacturing Facility	24/04
Lupin : April 22, 2024 Lupin Launches Mirabegron Extended-Release Tablets in the United States	22/04
INDIA STOCKS-Indian shares rise tracking Asia rebound; drop in HDFC Bank caps gains	22/04
Lupin Launches Mirabegron Extended-Release Tablets in US	22/04

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Lupin Limited

Actions

LUPIN

INE326A01037

Autres langues

Filtres